DAIICHI SANKYO, INC. for DAIICHI SANKYO INC
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 20, 2012 | $150,000 | Replaced |
| 1st Quarter - Amendment (this page) | Aug 24, 2012 | $180,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Discussions regarding Medicare Part D (H.R.2248/S. 44)
Foreign entity interest: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH LEE WRIGHT | — |
Copyright/Patent/Trademark CPT
Discussions regarding intellectual property protection and innovation.
Foreign entity interest: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LANCE GILGORE | — |
| ELIZABETH LEE WRIGHT | — |
Health Issues HCR
Discussions related to drug importation and IPAB (S.319, H.R. 147, H.R. 452) Discusions regarding Prescription Drug User Fee Act (PDUFA) (no bill #) Discussions regarding the Patient Protection and Affordable Care Act
Foreign entity interest: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH LEE WRIGHT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.